Andy Round
Investment Director @ Maven Capital Partners
Manchester, United Kingdom
Andy Round is a funding round investor at Maven Capital Partners in Manchester focused on Medical and Health Care. Based in our Manchester office, Andy is responsible for the execution of new investments across the Maven funds and works with investee companies across the region. He joined Maven in March 2018 following 8 years of experience managing Regional funds for both SPARK Impact and MSIF. Andy has previously worked for IP-Group investing in a range ofearly stage University companies across different sectors. At Yet2 as Consulting Director Andy provided services for companies such as Sumitomo Chemical, DSM, P+G, Unilever and Philips. Andy has a PhD in Biochemistry from the University of Leeds, the technology developed was incorporated into a company called Micap which went onto to raise £40m and was admitted to AiM.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Andy Round invests in
Stages Andy Round invests in
Countries Andy Round invests in
Investment Focus
Industry
- Medical 2 (100%)
- Health Care 2 (100%)
- Medical Device 2 (100%)
Stage
- Funding Round 1 (50%)
- Venture - Series Unknown 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Inotec AMD
|
Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way. | Feb 19, 2020 | |
Natrox
|
Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way. | $9M / Venture - Series Unknown / Feb 19, 2020 |
Co-Investors
About Maven Capital Partners
Maven Capital Partners was formed in 2009 following a management buyout of the private equity business of Aberdeen Asset Management PLC. Maven is now one of the UK’s leading private equity firms in the lower-mid market, specialising in investments in high-growth British companies. With a focus on innovation and value creation, Maven partners withvisionary entrepreneurs to build market-leading businesses, supporting a range of transaction types, including management buyouts, growth capital, buy-and-build projects, equity value release, and pre-IPO financing.Since 2009, Maven has also helped institutional, private client, and retail investors access private markets, including tax-efficient Venture Capital Trusts, deal-by-deal co-investment in private equity and property, and institutional buyout funds.
Maven Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andy Round
Investment Director
|
|||
Dave Furlong
Investment Director
|
|||
Gavin Bell
Investment Manager
|
|||
James Darlington
Investment Manager
|
|||
Jock Gardiner
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Andy Round invest in?
Andy Round invests primarily in Medical, Health Care and Medical Device startups, most often at Funding Round and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andy Round last invest?
The most recent investment recorded for Andy Round closed in Feb 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
